Security Snapshot

U S PHYSICAL THERAPY INC /NV - COMMON (USPH) Institutional Ownership

CUSIP: 90337L108

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

171

Shares (Excl. Options)

11.62MFull value: 11,619,219 · shares · 30 Sep 2026

Price

$85.73

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+892,963
Value change
+$78,409,071
Number of holders
171
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
14,855,576
SEC-reported price per share
$86.57
Insider filing price
$86.57
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • USPH - U S PHYSICAL THERAPY INC /NV - COMMON is tracked under CUSIP 90337L108.
  • 171 institutions reported positions in Q3 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 216 to 171 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $1.11BFull value: $1,112,679,111 · USD · 30 Jun 2026
    to
    $996.29MFull value: $996,292,595 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 171 institutions filings for Q3 2026.

Open SEC evidence

Security key

90337L108

13F reference period

Q3 2026

13F holders

171

13D/G owners

6

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
USPH
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14% $169,079,035 2,162,136 BlackRock, Inc. 30 Jun 2025
Neuberger Berman Group LLC 6.6% $83,771,186 980,468 Neuberger Berman Group LLC 30 Sep 2026
Copeland Capital Management, LLC 6.3% +13% $80,633,817 +$8,486,146 940,528 +12% Copeland Capital Management, LLC 30 Sep 2026
VANGUARD CAPITAL MANAGEMENT LLC 4.8% -6.4% $61,740,174 -$4,922,617 720,170 -7.4% Vanguard Capital Management 30 Sep 2026
MORGAN STANLEY 3.9% -33% $43,826,366 -$21,517,985 596,683 -33% Morgan Stanley 30 Jun 2026
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 3.5% -35% $44,674,098 -$27,665,728 522,871 -38% Kayne Anderson Rudnick Investment Management, LLC 30 Sep 2026
As of 30 Sep 2026, 171 institutional investors reported holding
11.62MFull value: 11,619,219 · shares · 30 Sep 2026
shares of U S PHYSICAL THERAPY INC /NV - COMMON (USPH). This represents 78% of the company’s total
14.86MFull value: 14,855,576 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
52%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
NEUBERGER BERMAN GROUP LLC 6.6% 980,468 0.06% $84,055,521
Bahl & Gaynor LLC 6% 889,265 0.36% $76,236,688
STATE STREET CORP 4.8% 719,455 0% $61,678,877
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 4.4% 659,509 0.18% $56,539,707
VANGUARD CAPITAL MANAGEMENT LLC 4.1% 606,474 0% $51,993,016
DIMENSIONAL FUND ADVISORS LP 3.6% 531,565 0.01% $45,571,325
SOUTHERNSUN ASSET MANAGEMENT, LLC 3.1% 466,503 6.1% $39,993,302
GEODE CAPITAL MANAGEMENT, LLC 2.6% 382,727 0% $32,817,810
SCHRODER INVESTMENT MANAGEMENT GROUP 2.5% 373,114 0.02% $32,143,771
VANGUARD PORTFOLIO MANAGEMENT LLC 2.2% 330,047 0% $28,294,929
BANK OF AMERICA CORP /DE/ 2.1% 305,721 0% $26,209,443
ENVESTNET ASSET MANAGEMENT INC 1.3% 198,566 0% $17,023,095
CRAWFORD INVESTMENT COUNSEL INC 1.1% 169,544 0.24% $14,534,996
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 0.99% 147,200 0.04% $12,619,456
KENNEDY CAPITAL MANAGEMENT LLC 0.99% 146,853 0.24% $12,589,708
WELLINGTON MANAGEMENT GROUP LLP 0.8% 119,146 0% $10,214,386
VANGUARD FIDUCIARY TRUST CO 0.7% 103,260 0% $8,852,480
Telemark Asset Management, LLC 0.67% 100,000 0.61% $8,573,000
Aristotle Capital Boston, LLC 0.66% 98,789 0.75% $8,469,250
MARSHALL WACE, LLP 0.59% 87,578 0.01% $7,508,062
Bridge City Capital, LLC 0.54% 80,585 1.4% $6,908,552
Bleakley Financial Group, LLC 0.54% 80,380 0.08% $6,890,977
Wilshire Advisors LLC 0.53% 78,927 0.02% $6,766,412
Invesco Ltd. 0.48% 71,225 0% $6,106,120
RBF Capital, LLC 0.47% 69,999 0.27% $6,001,014

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 11,619,219 $996,292,595 +$78,409,071 $85.73 171
2026 Q2 16,196,529 $1,112,679,111 +$7,960,962 $68.68 216
2026 Q1 16,053,966 $1,203,770,157 +$3,410,962 $74.96 228
2025 Q4 16,007,650 $1,251,280,500 -$3,483,427 $78.09 229
2025 Q3 16,025,734 $1,361,095,362 +$39,363,325 $84.95 244
2025 Q2 15,603,014 $1,220,352,681 +$28,791,118 $78.20 237
2025 Q1 15,293,795 $1,107,121,992 -$19,791,948 $72.36 252
2024 Q4 15,565,122 $1,381,034,235 +$12,224,751 $88.71 254
2024 Q3 15,433,476 $1,305,757,796 +$18,383,601 $84.63 254
2024 Q2 15,172,253 $1,402,254,310 -$59,249,178 $92.42 240
2024 Q1 15,618,754 $1,762,911,037 +$17,934,190 $112.87 234
2023 Q4 15,447,185 $1,438,773,106 +$3,869,053 $93.14 211
2023 Q3 15,398,086 $1,412,523,676 +$4,037,253 $91.73 216
2023 Q2 15,234,561 $1,848,475,452 +$186,901,768 $121.39 210
2023 Q1 13,701,294 $1,341,722,062 +$28,779,416 $97.91 195
2022 Q4 13,436,114 $1,088,773,930 +$71,739,919 $81.03 194
2022 Q3 13,124,739 $998,171,735 -$72,742,621 $76.02 189
2022 Q2 13,042,508 $1,423,973,455 +$34,859,639 $109.20 203
2022 Q1 12,815,293 $1,273,306,835 +$8,895,292 $99.45 203
2021 Q4 12,738,854 $1,217,788,483 -$20,797,020 $95.55 205
2021 Q3 12,685,017 $1,403,954,486 -$3,110,434 $110.60 203
2021 Q2 12,698,610 $1,471,332,128 +$13,558,739 $115.87 213
2021 Q1 12,599,376 $1,311,957,414 -$14,349,614 $104.10 206
2020 Q4 12,764,246 $1,535,159,218 -$22,751,760 $120.25 197
2020 Q3 12,985,104 $1,128,051,401 -$46,160,851 $86.88 176
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .